Logo image of ELV

ELEVANCE HEALTH INC (ELV) Stock Fundamental Analysis

NYSE:ELV - New York Stock Exchange, Inc. - US0367521038 - Common Stock - Currency: USD

412.49  +8.68 (+2.15%)

Premarket: 410.08 -2.41 (-0.58%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ELV. ELV was compared to 102 industry peers in the Health Care Providers & Services industry. While ELV is still in line with the averages on profitability rating, there are concerns on its financial health. ELV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

ELV had positive earnings in the past year.
In the past year ELV had a positive cash flow from operations.
ELV had positive earnings in each of the past 5 years.
In the past 5 years ELV always reported a positive cash flow from operatings.
ELV Yearly Net Income VS EBIT VS OCF VS FCFELV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

ELV's Return On Assets of 4.94% is fine compared to the rest of the industry. ELV outperforms 77.45% of its industry peers.
With an excellent Return On Equity value of 13.92%, ELV belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
ELV's Return On Invested Capital of 6.28% is fine compared to the rest of the industry. ELV outperforms 64.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ELV is below the industry average of 9.53%.
Industry RankSector Rank
ROA 4.94%
ROE 13.92%
ROIC 6.28%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ELV Yearly ROA, ROE, ROICELV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ELV has a better Profit Margin (3.23%) than 67.65% of its industry peers.
ELV's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 4.97%, ELV perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
In the last couple of years the Operating Margin of ELV has declined.
Industry RankSector Rank
OM 4.97%
PM (TTM) 3.23%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
ELV Yearly Profit, Operating, Gross MarginsELV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

More info and screens

2

2. Health

2.1 Basic Checks

ELV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ELV has less shares outstanding
Compared to 5 years ago, ELV has less shares outstanding
ELV has a worse debt/assets ratio than last year.
ELV Yearly Shares OutstandingELV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ELV Yearly Total Debt VS Total AssetsELV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of ELV is 8.32, which is on the high side as it means it would take ELV, 8.32 years of fcf income to pay off all of its debts.
ELV has a Debt to FCF ratio (8.32) which is in line with its industry peers.
ELV has a Debt/Equity ratio of 0.67. This is a neutral value indicating ELV is somewhat dependend on debt financing.
ELV has a Debt to Equity ratio of 0.67. This is comparable to the rest of the industry: ELV outperforms 54.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 8.32
Altman-Z N/A
ROIC/WACC0.81
WACC7.77%
ELV Yearly LT Debt VS Equity VS FCFELV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ELV Yearly Current Assets VS Current LiabilitesELV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.03% over the past year.
ELV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.17% yearly.
The Revenue has been growing slightly by 6.63% in the past year.
Measured over the past years, ELV shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)0.03%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)6.63%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%15.36%

3.2 Future

ELV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.36% yearly.
Based on estimates for the next years, ELV will show a small growth in Revenue. The Revenue will grow by 7.14% on average per year.
EPS Next Y5.45%
EPS Next 2Y9.78%
EPS Next 3Y11.35%
EPS Next 5Y12.36%
Revenue Next Year11.01%
Revenue Next 2Y9.05%
Revenue Next 3Y8.63%
Revenue Next 5Y7.14%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ELV Yearly Revenue VS EstimatesELV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50B 100B 150B 200B
ELV Yearly EPS VS EstimatesELV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.03, the valuation of ELV can be described as correct.
ELV's Price/Earnings ratio is rather cheap when compared to the industry. ELV is cheaper than 86.27% of the companies in the same industry.
When comparing the Price/Earnings ratio of ELV to the average of the S&P500 Index (26.60), we can say ELV is valued rather cheaply.
A Price/Forward Earnings ratio of 10.38 indicates a reasonable valuation of ELV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELV indicates a rather cheap valuation: ELV is cheaper than 87.25% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.43, ELV is valued rather cheaply.
Industry RankSector Rank
PE 12.03
Fwd PE 10.38
ELV Price Earnings VS Forward Price EarningsELV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELV is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
ELV's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 25.83
EV/EBITDA 10.97
ELV Per share dataELV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.21
PEG (5Y)1.08
EPS Next 2Y9.78%
EPS Next 3Y11.35%

More info and screens

6

5. Dividend

5.1 Amount

ELV has a Yearly Dividend Yield of 1.75%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.46, ELV pays a better dividend. On top of this ELV pays more dividend than 89.22% of the companies listed in the same industry.
ELV's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

The dividend of ELV is nicely growing with an annual growth rate of 15.34%!
ELV has paid a dividend for at least 10 years, which is a reliable track record.
ELV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.34%
Div Incr Years13
Div Non Decr Years13
ELV Yearly Dividends per shareELV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ELV pays out 25.60% of its income as dividend. This is a sustainable payout ratio.
The dividend of ELV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP25.6%
EPS Next 2Y9.78%
EPS Next 3Y11.35%
ELV Yearly Income VS Free CF VS DividendELV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
ELV Dividend Payout.ELV Dividend Payout, showing the Payout Ratio.ELV Dividend Payout.PayoutRetained Earnings

More info and screens

ELEVANCE HEALTH INC

NYSE:ELV (5/20/2025, 8:04:00 PM)

Premarket: 410.08 -2.41 (-0.58%)

412.49

+8.68 (+2.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-22 2025-04-22/bmo
Earnings (Next)07-15 2025-07-15/amc
Inst Owners91.45%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner Change7.32%
Market Cap93.19B
Analysts79.29
Price Target508.15 (23.19%)
Short Float %1.19%
Short Ratio1.58
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend6.55
Dividend Growth(5Y)15.34%
DP25.6%
Div Incr Years13
Div Non Decr Years13
Ex-Date06-10 2025-06-10 (1.71)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.14%
Min EPS beat(2)0.17%
Max EPS beat(2)4.12%
EPS beat(4)3
Avg EPS beat(4)-2.45%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)6
Avg EPS beat(8)-0.5%
EPS beat(12)9
Avg EPS beat(12)0.34%
EPS beat(16)12
Avg EPS beat(16)1.48%
Revenue beat(2)1
Avg Revenue beat(2)1.8%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)4.3%
Revenue beat(4)2
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)3
Avg Revenue beat(8)0.68%
Revenue beat(12)6
Avg Revenue beat(12)0.74%
Revenue beat(16)9
Avg Revenue beat(16)0.66%
PT rev (1m)0.31%
PT rev (3m)0.67%
EPS NQ rev (1m)-4.57%
EPS NQ rev (3m)-7.53%
EPS NY rev (1m)0.6%
EPS NY rev (3m)0.81%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)1.33%
Revenue NY rev (1m)0.74%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 12.03
Fwd PE 10.38
P/S 0.51
P/FCF 25.83
P/OCF 19.49
P/B 2.19
P/tB 43.49
EV/EBITDA 10.97
EPS(TTM)34.3
EY8.32%
EPS(NY)39.73
Fwd EY9.63%
FCF(TTM)15.97
FCFY3.87%
OCF(TTM)21.16
OCFY5.13%
SpS810.53
BVpS188.12
TBVpS9.49
PEG (NY)2.21
PEG (5Y)1.08
Profitability
Industry RankSector Rank
ROA 4.94%
ROE 13.92%
ROCE 8.21%
ROIC 6.28%
ROICexc 6.73%
ROICexgc 12.57%
OM 4.97%
PM (TTM) 3.23%
GM N/A
FCFM 1.97%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexcg growth 3Y-5.49%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 8.32
Debt/EBITDA 2.69
Cap/Depr 81.74%
Cap/Sales 0.64%
Interest Coverage 250
Cash Conversion 45.41%
Profit Quality 60.98%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC7.77%
ROIC/WACC0.81
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)0.03%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%12.5%
EPS Next Y5.45%
EPS Next 2Y9.78%
EPS Next 3Y11.35%
EPS Next 5Y12.36%
Revenue 1Y (TTM)6.63%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%15.36%
Revenue Next Year11.01%
Revenue Next 2Y9.05%
Revenue Next 3Y8.63%
Revenue Next 5Y7.14%
EBIT growth 1Y-7.51%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year10.19%
EBIT Next 3Y10.57%
EBIT Next 5Y11.36%
FCF growth 1Y-67.58%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-61.22%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%